期刊文献+

血清脂联素水平与冠状动脉病变程度的关系 被引量:33

The relationship between serum level of adiponectin and severity of coronary artery stenosis
原文传递
导出
摘要 目的 :研究血清脂联素与冠状动脉 (冠脉 )病变狭窄程度的相关性以及对血管病变稳定性的预测价值。方法 :入选 10 5例男性患者 ,分为 3组 ,急性冠脉综合征 (ACS)患者 5 1例 ,稳定型心绞痛 (SAP)患者 2 9例 ,非冠心病对照组 2 5例 ,进行血清脂联素测定 ,采用Gensini积分系统评定冠脉血管病变狭窄程度。结果 :ACS组血清脂联素水平的对数值 [(0 .6 4± 0 .18)mg/L]明显低于SAP组和对照组 [(0 .81± 0 .2 1)、(0 .81± 0 .2 8)mg/L],均P <0 .0 1。而SAP组和对照组之间差异无统计学意义 (P >0 .0 5 )。脂联素与冠脉病变程度Gensini积分呈负相关 (r =- 0 .38,P <0 .0 1)。结论 :脂联素与冠脉狭窄程度以及稳定性显著相关 ,有助于临床评价冠心病病变程度及其进展。 Objective: To investigate the relationship between the level of serum adiponectin and the severity,stability of coronary artery stenosis. Method:We studied total of 105 male patients. Serum concentration of adiponectin in 51 patients with acute coronary syndrome(ACS),29 patients with stable angina pectoris(SAP) ,diagnosed by coronary angiograph, were measured . There were 25 normal control subjects.The severity scale of coronary artery stenosis was quantatively assessed according to coronory angiography by Gensini score. Result: The serum levels of adiponectin in ACS patients were significantly descended as compared with that of SAP and controls(P< 0.01),and serum adiponectin concentration were negatively correlated with the severity of coronaru artery stenosis(r=- 0.38,P< 0.01). Conclusion:Adiponectin reflects the severity and stability of coronary artery stenosis which may predicts the occurrence and development of coronary artery disease.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2004年第10期619-621,共3页 Journal of Clinical Cardiology
  • 相关文献

参考文献11

  • 1Arita Y, Kihara S, Ouchi N,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun, 1999, 257: 79-83.
  • 2Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specificprotein, adiponectin. in type 2 diabetic patients. Arterioscler Thromb Vase Biol,2000, 20:1595-1599.
  • 3Matsubara M, Maruoka S, Katayose S. Decreased Plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002 ,87: 2764-2769.
  • 4Kumada M, Kihara S, Sumitsuji S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler, Thromb Vasc Biol, 2003,23: 85 -89.
  • 5Engeli S. Feldpausch M, Girzekbeak K, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003 ,52:942-947.
  • 6Matsuda M. Shimomura 1. Sara M, et al. Role of adi ponectin in preventing vascular stenosis. J Biol Chem,2002, 277:37487-37491.
  • 7Kubota N. Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277:25863-25866.
  • 8Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protain, adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001 ,103:1057- 1063.
  • 9Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFκB signaling through a cAMP dependent pathway. Cir culation, 2000,102:1296-1301.
  • 10Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100:2473-2476.

同被引文献361

引证文献33

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部